| Hypoxia is a major stimulator of osteoclast formation and bone resorption TR Arnett, DC Gibbons, JC Utting, IR Orriss, A Hoebertz, M Rosendaal, ... Journal of cellular physiology 196 (1), 2-8, 2003 | 400 | 2003 |
| Reducing inappropriate accident and emergency department attendances:: a systematic review of primary care service interventions SA Ismail, DC Gibbons, S Gnani British Journal of General Practice 63 (617), e813-e820, 2013 | 186 | 2013 |
| Risk factors predicting desmoid occurrence in patients with familial adenomatous polyposis: a meta‐analysis A Sinha, PP Tekkis, DC Gibbons, RK Phillips, SK Clark Colorectal Disease 13 (11), 1222-1229, 2011 | 133 | 2011 |
| Access to general practice and visits to accident and emergency departments in England: cross-sectional analysis of a national patient survey TE Cowling, MJ Harris, HC Watt, DC Gibbons, A Majeed British Journal of General Practice 64 (624), e434-e439, 2014 | 99 | 2014 |
| Rapid testing and treatment for sexually transmitted infections improve patient care and yield public health benefits GG Whitlock, DC Gibbons, N Longford, MJ Harvey, A McOwan, EJ Adams International journal of STD & AIDS 29 (5), 474-482, 2018 | 67 | 2018 |
| Increasing the age for the legal purchase of tobacco in England: impacts on socio-economic disparities in youth smoking C Millett, JT Lee, DC Gibbons, SA Glantz Thorax 66 (10), 862-865, 2011 | 60 | 2011 |
| Defining primary care sensitive conditions: a necessity for effective primary care delivery? DC Gibbons, AB Bindman, MA Soljak, C Millett, A Majeed Journal of the Royal Society of Medicine 105 (10), 422-428, 2012 | 51 | 2012 |
| Colorectal cancer: no longer the issue in familial adenomatous polyposis? DC Gibbons, A Sinha, RKS Phillips, SK Clark Familial cancer 10, 11-20, 2011 | 50 | 2011 |
| Real-world effectiveness of sotrovimab for the early treatment of COVID-19 during SARS-CoV-2 Delta and Omicron waves in the USA MM Cheng, C Reyes, S Satram, H Birch, DC Gibbons, M Drysdale, ... Infectious diseases and therapy 12 (2), 607-621, 2023 | 29 | 2023 |
| Characteristics and outcomes of patients with COVID-19 at high-risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England V Patel, MJ Yarwood, B Levick, DC Gibbons, M Drysdale, W Kerr, ... medRxiv, 2022.11. 28.22282808, 2022 | 18 | 2022 |
| Treatment patterns among non-active users of maintenance asthma medication in the United Kingdom: a retrospective cohort study in the Clinical Practice Research Datalink DC Gibbons, B Aggarwal, J Fairburn-Beech, D Hinds, M Fletcher, ... Journal of Asthma 58 (6), 793-804, 2021 | 15 | 2021 |
| Surgical prophylaxis in familial adenomatous polyposis: do pre-existing desmoids outside the abdominal cavity matter? A Sinha, DC Gibbons, RK Phillips, S Clark Familial Cancer 9 (3), 407-411, 2010 | 11 | 2010 |
| The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom G Requena, J Logie, DC Gibbons, J Steinfeld, MK Van Dyke Immunity, Inflammation and Disease 9 (4), 1447-1451, 2021 | 9 | 2021 |
| Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA. 2 and BA. 5 subvariant predominance: A systematic literature review M Drysdale, M Berktas, DC Gibbons, C Rolland, L Lavoie, EJ Lloyd Infection, 1-23, 2024 | 8 | 2024 |
| Treatment patterns, healthcare resource use, and costs associated with uncomplicated urinary tract infection among female patients in the United States RC Moon, A Marijam, FS Mitrani-Gold, DC Gibbons, A Kartashov, ... Plos one 17 (11), e0277713, 2022 | 8 | 2022 |
| Real-world effectiveness of sotrovimab for the early treatment of COVID-19 during SARS-CoV-2 Delta and Omicron waves in the United States MM Cheng, C Reyes, S Satram, H Birch, DC Gibbons, M Drysdale, ... medRxiv, 2022.09. 07.22279497, 2022 | 7 | 2022 |
| Use of hospital admissions data to quantify the burden of emergency admissions in people with diabetes mellitus DC Gibbons, MA Soljak, C Millett, J Valabhji, A Majeed Diabetic medicine 31 (8), 971-975, 2014 | 7 | 2014 |
| Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England V Patel, B Levick, S Boult, DC Gibbons, M Drysdale, EJ Lloyd, M Singh, ... BMC Infectious Diseases 24 (1), 428, 2024 | 6 | 2024 |
| Disease burden of primary biliary cholangitis and associated pruritus based on a cross-sectional US claims analysis U Gungabissoon, DC Gibbons, G Requena, AR de Souza, H Smith BMJ Open Gastroenterology 9 (1), e000857, 2022 | 5 | 2022 |
| Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in Scotland M Drysdale, H Tibble, V Patel, DC Gibbons, E Lloyd, W Kerr, ... medRxiv, 2023.06. 09.23291195, 2023 | 2 | 2023 |
Tim ArnettDept of Cell & Developmental Biology, UCL在 ucl.ac.uk 的电子邮件经过验证
